Literature DB >> 8278021

Neuronophagia in the motor cortex in amyotrophic lateral sclerosis.

D Troost1, N Claessen, J J van den Oord, D F Swaab, J M de Jong.   

Abstract

This study was designed to identify which phagocytic cells in the cerebral cortex of amyotrophic lateral sclerosis (ALS) patients are involved in the process of neuronophagia. For this purpose a number of single and double immunocytochemical stains were carried out on five ALS cases which were selected on the basis of the presence of degenerative and phagocytic phenomena in the cerebral cortex. The cortical degenerative process is mainly present in the third and fifth layers and is not restricted to the fifth layer which contains the cell bodies of the Betz cells. The present study indicates that a number of cells are involved in the process of phagocytosis in ALS. Resident macrophages (from microglial or perivascular origin) and astrocytes seem to play an immunologically-mediated role in the disappearance of neurons. Some of the cells involved in the degenerative process, i.e. rounded macrophages and microglia, expressed major histocompatibility class II antigen. The phagocytic cells in neuronophagia were phenotypically identical to perivascular macrophages and not to microglia. Therefore, the process of phagocytosis of neurons appears to be primarily the task of the perivascularly located macrophage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8278021     DOI: 10.1111/j.1365-2990.1993.tb00459.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  8 in total

Review 1.  Immunological findings in amyotrophic lateral sclerosis.

Authors:  J P Antel; N R Cashman
Journal:  Springer Semin Immunopathol       Date:  1995

Review 2.  Prospects for the pharmacotherapy of amyotrophic lateral sclerosis : old strategies and new paradigms for the third millennium.

Authors:  Barry W Festoff; Zhiming Suo; Bruce A Citron
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

3.  Immunophenotypic evidence for distinct populations of microglia in the rat hypothalamo-neurohypophysial system.

Authors:  T H Mander; J F Morris
Journal:  Cell Tissue Res       Date:  1995-06       Impact factor: 5.249

4.  Autoimmunity in amyotrophic lateral sclerosis: past and present.

Authors:  Mario Rafael Pagani; Laura Elisabeth Gonzalez; Osvaldo Daniel Uchitel
Journal:  Neurol Res Int       Date:  2011-08-01

5.  A comparison of in vitro properties of resting SOD1 transgenic microglia reveals evidence of reduced neuroprotective function.

Authors:  Siranush A Sargsyan; Daniel J Blackburn; Siân C Barber; Julian Grosskreutz; Kurt J De Vos; Peter N Monk; Pamela J Shaw
Journal:  BMC Neurosci       Date:  2011-09-23       Impact factor: 3.288

Review 6.  What does imaging reveal about the pathology of amyotrophic lateral sclerosis?

Authors:  Martin R Turner; Esther Verstraete
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

7.  CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis.

Authors:  Elizabeth Gray; Alexander G Thompson; Joanne Wuu; Joe Pelt; Kevin Talbot; Michael Benatar; Martin R Turner
Journal:  Ann Clin Transl Neurol       Date:  2020-07-14       Impact factor: 4.511

8.  Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis.

Authors:  Huaqian Dong; Xiang Ye; Li Zhong; Jinhong Xu; Jinhua Qiu; Jun Wang; Yiming Shao; Huiqin Xing
Journal:  Front Neurosci       Date:  2019-02-04       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.